The first few trading days of January have reminded investors that we’re still operating in a manic market. Each of the major indexes has closed at a new all-time high in January, and as of the market opening on Jan. 8, all the indexes were positive for the year.
Source: https://www.marketbeat.com/originals/3-stocks-positioned-for…
CVE, TTE and CPCAY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 21st, 2026.
The only drug named in Trump’s executive order is ibogaine, a psychedelic commonly used to treat depression, anxiety and PTSD among veterans. The drug, a Schedule I substance banned in the U.S., has been backed by Republicans in Texas in recent years who argue in favor of ibogaine’s success with veterans.
A notable shift has been unfolding beneath the surface of the market in recent months, one that many investors may have overlooked. While the major indexes have remained flat or pushed modestly higher, leadership has quietly rotated.
